Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 91 entries
Sorted by: Best Match Show Resources per page
[Enterosolvent envelopes of some dosed drugs].

Ceskoslovenska farmacie

MELICHAR M, CHALABALA M, MALY J.
PMID: 14379227
Cesk Farm. 1954 Nov;3(9):315-23.

No abstract available.

Cite
MELICHAR M, CHALABALA M, MALY J. Enterosolventnä obaly nĕkterých dávkovanych léků. [Enterosolvent envelopes of some dosed drugs]. Cesk Farm. 1954;3(9):315-23
MELICHAR, M., CHALABALA, M., & MALY, J. (1954). Enterosolventnä obaly nĕkterých dávkovanych léků. [Enterosolvent envelopes of some dosed drugs]. Ceskoslovenska farmacie, 3(9), 315-23.
MELICHAR, M, et al. "Enterosolventnä obaly nĕkterých dávkovanych léků." [Enterosolvent envelopes of some dosed drugs]. Ceskoslovenska farmacie vol. 3,9 (1954): 315-23.
MELICHAR M, CHALABALA M, MALY J. Enterosolventnä obaly nĕkterých dávkovanych léků. [Enterosolvent envelopes of some dosed drugs]. Cesk Farm. 1954 Nov;3(9):315-23. Czech. PMID: 14379227.
Copy Download .nbib Format: NLM
Protective regime and inhibition therapy in the care of premature infants.

Review of Czechoslovak medicine

ZNAMENACEK K, MELICHAR V.
PMID: 13847687
Rev Czech Med. 1960;6:15-20.

No abstract available.

Cite
ZNAMENACEK K, MELICHAR V. Protective regime and inhibition therapy in the care of premature infants. Rev Czech Med. 1960;6:15-20
ZNAMENACEK, K., & MELICHAR, V. (1960). Protective regime and inhibition therapy in the care of premature infants. Review of Czechoslovak medicine, 615-20.
ZNAMENACEK, K, and MELICHAR, V. "Protective regime and inhibition therapy in the care of premature infants." Review of Czechoslovak medicine vol. 6 (1960): 15-20.
ZNAMENACEK K, MELICHAR V. Protective regime and inhibition therapy in the care of premature infants. Rev Czech Med. 1960;6:15-20. PMID: 13847687.
Copy Download .nbib Format: NLM
[Quality indexes of drugs; technology of optimal determination of the diameter of pills].

Ceskoslovenska farmacie

MELICHAR M.
PMID: 13009703
Cesk Farm. 1952;1(10):574-6.

No abstract available.

Cite
MELICHAR M. Studie jakostnich indexů lékových forem. IV. Technologicky optimalni průmer válence pri priprave pilulek. [Quality indexes of drugs; technology of optimal determination of the diameter of pills]. Cesk Farm. 1952;1(10):574-6
MELICHAR, M. (1952). Studie jakostnich indexů lékových forem. IV. Technologicky optimalni průmer válence pri priprave pilulek. [Quality indexes of drugs; technology of optimal determination of the diameter of pills]. Ceskoslovenska farmacie, 1(10), 574-6.
MELICHAR, M. "Studie jakostnich indexů lékových forem. IV. Technologicky optimalni průmer válence pri priprave pilulek." [Quality indexes of drugs; technology of optimal determination of the diameter of pills]. Ceskoslovenska farmacie vol. 1,10 (1952): 574-6.
MELICHAR M. Studie jakostnich indexů lékových forem. IV. Technologicky optimalni průmer válence pri priprave pilulek. [Quality indexes of drugs; technology of optimal determination of the diameter of pills]. Cesk Farm. 1952;1(10):574-6. Undetermined. PMID: 13009703.
Copy Download .nbib Format: NLM
[On diagnostic errors in roentgen diagnosis].

Ceskoslovenska rentgenologie

MELICHAR B.
PMID: 13934670
Cesk Rentgenol. 1963 Mar;17:101-3.

No abstract available.

Cite
MELICHAR B. [On diagnostic errors in roentgen diagnosis]. Cesk Rentgenol. 1963;17:101-3
MELICHAR, B. (1963). [On diagnostic errors in roentgen diagnosis]. Ceskoslovenska rentgenologie, 17101-3.
MELICHAR, B. "[On diagnostic errors in roentgen diagnosis]." Ceskoslovenska rentgenologie vol. 17 (1963): 101-3.
MELICHAR B. [On diagnostic errors in roentgen diagnosis]. Cesk Rentgenol. 1963 Mar;17:101-3. Czech. PMID: 13934670.
Copy Download .nbib Format: NLM
[Healing power--An art of natural healing of people or yet only by natural therapy?].

Forschende Komplementarmedizin und klassische Naturheilkunde = Research in complementary and natural classical medicine

Melchart D.
PMID: 15604622
Forsch Komplementarmed Klass Naturheilkd. 2004 Dec;11(6):324-5. doi: 10.1159/000082812.

No abstract available.

Cite
Melchart D. Die Naturheilkunde -- Eine Kunde von der naturlichen Heilkraft des Menschen oder doch nur von den naturlichen Heilverfahren? [Healing power--An art of natural healing of people or yet only by natural therapy?]. Forsch Komplementarmed Klass Naturheilkd. 2004;11(6):324-5doi: 10.1159/000082812.
Melchart, D. (2004). Die Naturheilkunde -- Eine Kunde von der naturlichen Heilkraft des Menschen oder doch nur von den naturlichen Heilverfahren? [Healing power--An art of natural healing of people or yet only by natural therapy?]. Forschende Komplementarmedizin und klassische Naturheilkunde = Research in complementary and natural classical medicine, 11(6), 324-5. https://doi.org/10.1159/000082812
Melchart, D. "Die Naturheilkunde -- Eine Kunde von der naturlichen Heilkraft des Menschen oder doch nur von den naturlichen Heilverfahren?" [Healing power--An art of natural healing of people or yet only by natural therapy?]. Forschende Komplementarmedizin und klassische Naturheilkunde = Research in complementary and natural classical medicine vol. 11,6 (2004): 324-5. doi: https://doi.org/10.1159/000082812
Melchart D. Die Naturheilkunde -- Eine Kunde von der naturlichen Heilkraft des Menschen oder doch nur von den naturlichen Heilverfahren? [Healing power--An art of natural healing of people or yet only by natural therapy?]. Forsch Komplementarmed Klass Naturheilkd. 2004 Dec;11(6):324-5. doi: 10.1159/000082812. German. PMID: 15604622.
Copy Download .nbib Format: NLM
Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs.

Medicines (Basel, Switzerland)

Teschke R, Larrey D, Melchart D, Danan G.
PMID: 28930128
Medicines (Basel). 2016 Jul 19;3(3). doi: 10.3390/medicines3030018.

No abstract available.

Cite
Teschke R, Larrey D, Melchart D, et al. Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs. Medicines (Basel). 2016;3(3)doi: 10.3390/medicines3030018.
Teschke, R., Larrey, D., Melchart, D., & Danan, G. (2016). Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs. Medicines (Basel, Switzerland), 3(3), . https://doi.org/10.3390/medicines3030018
Teschke, Rolf, et al. "Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs." Medicines (Basel, Switzerland) vol. 3,3 (2016). doi: https://doi.org/10.3390/medicines3030018
Teschke R, Larrey D, Melchart D, Danan G. Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs. Medicines (Basel). 2016 Jul 19;3(3). doi: 10.3390/medicines3030018. PMID: 28930128; PMCID: PMC5456249.
Copy Download .nbib Format: NLM
Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new potential hereditary genetic alterations.

Cancer management and research

Lovecek M, Janatova M, Skalicky P, Zemanek T, Havlik R, Ehrmann J, Strouhal O, Zemankova P, Lhotova K, Borecka M, Soukupova J, Svebisova H, Soucek P, Hlavac V, Kleibl Z, Neoral C, Melichar B, Mohelnikova-Duchonova B.
PMID: 30666157
Cancer Manag Res. 2019 Jan 10;11:599-609. doi: 10.2147/CMAR.S185352. eCollection 2019.

BACKGROUND: The principal aim of this report was to study second primary malignant neoplasms (SMNs) in long-term survivors of pancreatic ductal adenocarcinoma (PDAC) with regard to the germline genetic background.PATIENTS AND METHODS: A total of 118 PDAC patients after...

Cite
Lovecek M, Janatova M, Skalicky P, et al. Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new potential hereditary genetic alterations. Cancer Manag Res. 2019;11:599-609doi: 10.2147/CMAR.S185352.
Lovecek, M., Janatova, M., Skalicky, P., Zemanek, T., Havlik, R., Ehrmann, J., Strouhal, O., Zemankova, P., Lhotova, K., Borecka, M., Soukupova, J., Svebisova, H., Soucek, P., Hlavac, V., Kleibl, Z., Neoral, C., Melichar, B., & Mohelnikova-Duchonova, B. (2019). Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new potential hereditary genetic alterations. Cancer management and research, 11599-609. https://doi.org/10.2147/CMAR.S185352
Lovecek, Martin, et al. "Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new potential hereditary genetic alterations." Cancer management and research vol. 11 (2019): 599-609. doi: https://doi.org/10.2147/CMAR.S185352
Lovecek M, Janatova M, Skalicky P, Zemanek T, Havlik R, Ehrmann J, Strouhal O, Zemankova P, Lhotova K, Borecka M, Soukupova J, Svebisova H, Soucek P, Hlavac V, Kleibl Z, Neoral C, Melichar B, Mohelnikova-Duchonova B. Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new potential hereditary genetic alterations. Cancer Manag Res. 2019 Jan 10;11:599-609. doi: 10.2147/CMAR.S185352. eCollection 2019. PMID: 30666157; PMCID: PMC6331079.
Copy Download .nbib Format: NLM
Multimodal Treatment of Patients with Mental Symptom Load: A Pre-Post Comparison.

Journal of clinical medicine

Melchart D, Fischer V, Dai J, Hager S, Dersch L, Bachmeier BE.
PMID: 31623396
J Clin Med. 2019 Oct 03;8(10). doi: 10.3390/jcm8101610.

The Traditional Chinese Medicine (TCM) Hospital in Bad Kötzting, Germany, is treating chronically ill patients, covering a broad range of indications. The aim of this study was to prove the efficacy of a multimodal intervention combining mainstream medicine with...

Cite
Melchart D, Fischer V, Dai J, et al. Multimodal Treatment of Patients with Mental Symptom Load: A Pre-Post Comparison. J Clin Med. 2019;8(10)doi: 10.3390/jcm8101610.
Melchart, D., Fischer, V., Dai, J., Hager, S., Dersch, L., & Bachmeier, B. E. (2019). Multimodal Treatment of Patients with Mental Symptom Load: A Pre-Post Comparison. Journal of clinical medicine, 8(10), . https://doi.org/10.3390/jcm8101610
Melchart, Dieter, et al. "Multimodal Treatment of Patients with Mental Symptom Load: A Pre-Post Comparison." Journal of clinical medicine vol. 8,10 (2019). doi: https://doi.org/10.3390/jcm8101610
Melchart D, Fischer V, Dai J, Hager S, Dersch L, Bachmeier BE. Multimodal Treatment of Patients with Mental Symptom Load: A Pre-Post Comparison. J Clin Med. 2019 Oct 03;8(10). doi: 10.3390/jcm8101610. PMID: 31623396; PMCID: PMC6832432.
Copy Download .nbib Format: NLM
Understanding Failure Mode Effect Analysis Data Using Interactive Visual Analytics.

IEEE computer graphics and applications

Basole RC, Qamar A, Pal B, Corral M, Meinhart M, Narechania A, Potel M.
PMID: 31714212
IEEE Comput Graph Appl. 2019 Nov-Dec;39(6):17-26. doi: 10.1109/MCG.2019.2944230.

Providing actionable insights through interactive visual analytics is essential to effective decision making. Yet, many complex systems engineering (SE) domains still lack such tools. Design reviews are often still based on static snapshots of data, without any dynamic interaction,...

Cite
Basole RC, Qamar A, Pal B, et al. Understanding Failure Mode Effect Analysis Data Using Interactive Visual Analytics. IEEE Comput Graph Appl. 2019;39(6):17-26doi: 10.1109/MCG.2019.2944230.
Basole, R. C., Qamar, A., Pal, B., Corral, M., Meinhart, M., Narechania, A., & Potel, M. (2019). Understanding Failure Mode Effect Analysis Data Using Interactive Visual Analytics. IEEE computer graphics and applications, 39(6), 17-26. https://doi.org/10.1109/MCG.2019.2944230
Basole, Rahul C, et al. "Understanding Failure Mode Effect Analysis Data Using Interactive Visual Analytics." IEEE computer graphics and applications vol. 39,6 (2019): 17-26. doi: https://doi.org/10.1109/MCG.2019.2944230
Basole RC, Qamar A, Pal B, Corral M, Meinhart M, Narechania A, Potel M. Understanding Failure Mode Effect Analysis Data Using Interactive Visual Analytics. IEEE Comput Graph Appl. 2019 Nov-Dec;39(6):17-26. doi: 10.1109/MCG.2019.2944230. PMID: 31714212.
Copy Download .nbib Format: NLM
Non-invasive determination of uric acid in human saliva in the diagnosis of serious disorders.

Clinical chemistry and laboratory medicine

Vernerová A, Kujovská Krčmová L, Melichar B, Švec F.
PMID: 33554551
Clin Chem Lab Med. 2020 Nov 30;59(5):797-812. doi: 10.1515/cclm-2020-1533. Print 2021 Apr 27.

This review summarizes and critically evaluates the published approaches and recent trends in sample pre-treatment, as well as both separation and non-separation techniques used for the determination of uric acid (UA) in saliva. UA is the final product of...

Cite
Vernerová A, Kujovská Krčmová L, Melichar B, et al. Non-invasive determination of uric acid in human saliva in the diagnosis of serious disorders. Clin Chem Lab Med. 2020;59(5):797-812doi: 10.1515/cclm-2020-1533.
Vernerová, A., Kujovská Krčmová, L., Melichar, B., & Švec, F. (2021). Non-invasive determination of uric acid in human saliva in the diagnosis of serious disorders. Clinical chemistry and laboratory medicine, 59(5), 797-812. https://doi.org/10.1515/cclm-2020-1533
Vernerová, Andrea, et al. "Non-invasive determination of uric acid in human saliva in the diagnosis of serious disorders." Clinical chemistry and laboratory medicine vol. 59,5 (2021): 797-812. doi: https://doi.org/10.1515/cclm-2020-1533
Vernerová A, Kujovská Krčmová L, Melichar B, Švec F. Non-invasive determination of uric acid in human saliva in the diagnosis of serious disorders. Clin Chem Lab Med. 2020 Nov 30;59(5):797-812. doi: 10.1515/cclm-2020-1533. Print 2021 Apr 27. PMID: 33554551.
Copy Download .nbib Format: NLM
Mental health of clinic-attending Syrian refugee women in Jordan: associations between social ecological risks factors and mental health symptoms.

BMC women's health

Brooks MA, Meinhart M, Samawi L, Mukherjee T, Jaber R, Alhomsh H, Kaushal N, Al Qutob R, Khadra M, El-Bassel N, Dasgupta A.
PMID: 34996436
BMC Womens Health. 2022 Jan 08;22(1):4. doi: 10.1186/s12905-021-01584-y.

BACKGROUND: The mental health of refugee women is often affected by multiple risk factors in their social ecology. Assessing these risk factors is foundational in determining potential areas for intervention. We used the social ecological model to examine risk...

Cite
Brooks MA, Meinhart M, Samawi L, et al. Mental health of clinic-attending Syrian refugee women in Jordan: associations between social ecological risks factors and mental health symptoms. BMC Womens Health. 2022;22(1):4doi: 10.1186/s12905-021-01584-y.
Brooks, M. A., Meinhart, M., Samawi, L., Mukherjee, T., Jaber, R., Alhomsh, H., Kaushal, N., Al Qutob, R., Khadra, M., El-Bassel, N., & Dasgupta, A. (2022). Mental health of clinic-attending Syrian refugee women in Jordan: associations between social ecological risks factors and mental health symptoms. BMC women's health, 22(1), 4. https://doi.org/10.1186/s12905-021-01584-y
Brooks, Mohamad Adam, et al. "Mental health of clinic-attending Syrian refugee women in Jordan: associations between social ecological risks factors and mental health symptoms." BMC women's health vol. 22,1 (2022): 4. doi: https://doi.org/10.1186/s12905-021-01584-y
Brooks MA, Meinhart M, Samawi L, Mukherjee T, Jaber R, Alhomsh H, Kaushal N, Al Qutob R, Khadra M, El-Bassel N, Dasgupta A. Mental health of clinic-attending Syrian refugee women in Jordan: associations between social ecological risks factors and mental health symptoms. BMC Womens Health. 2022 Jan 08;22(1):4. doi: 10.1186/s12905-021-01584-y. PMID: 34996436; PMCID: PMC8742365.
Copy Download .nbib Format: NLM
Pembrolizumab plus axitinib for the treatment of advanced renal cell carcinoma.

Expert review of anticancer therapy

Spisarová M, Melichar B, Vitásková D, Študentová H.
PMID: 33794744
Expert Rev Anticancer Ther. 2021 Jul;21(7):693-703. doi: 10.1080/14737140.2021.1903321. Epub 2021 Apr 02.

No abstract available.

Cite
Spisarová M, Melichar B, Vitásková D, et al. Pembrolizumab plus axitinib for the treatment of advanced renal cell carcinoma. Expert Rev Anticancer Ther. 2021;21(7):693-703doi: 10.1080/14737140.2021.1903321.
Spisarová, M., Melichar, B., Vitásková, D., & Študentová, H. (2021). Pembrolizumab plus axitinib for the treatment of advanced renal cell carcinoma. Expert review of anticancer therapy, 21(7), 693-703. https://doi.org/10.1080/14737140.2021.1903321
Spisarová, Martina, et al. "Pembrolizumab plus axitinib for the treatment of advanced renal cell carcinoma." Expert review of anticancer therapy vol. 21,7 (2021): 693-703. doi: https://doi.org/10.1080/14737140.2021.1903321
Spisarová M, Melichar B, Vitásková D, Študentová H. Pembrolizumab plus axitinib for the treatment of advanced renal cell carcinoma. Expert Rev Anticancer Ther. 2021 Jul;21(7):693-703. doi: 10.1080/14737140.2021.1903321. Epub 2021 Apr 02. PMID: 33794744.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 91 entries